Doctor profile · Federal record
Dr. Asif Ali, DO
Anesthesiology Physician (CMS: Anesthesiology) · Interventional Pain Medicine Physician · Sugar Land, TX
- NPI 1972941904
- Accepts Medicare
- 13 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
12440 Emily CT Ste 701
Sugar Land, TX 774784543
(406) 476-8227 - Additional location
-
2500 E T C Jester Blvd
Houston, TX 770081365
(405) 476-8227
Credentials & registration
- NPI registered
- June 2013 — 13 yrs on file
- Profile last updated
- October 21, 2024
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207L00000X — NUCC code
- State license (1)
- Texas #R7157
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972941904. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,127
Distinct HCPCS
10
Medicare allowed
$304,857
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
80307 |
Testing for presence of drug, by chemistry analyzers | 441 | 209 | $61 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 429 | 82 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 326 | 170 | $120 | |
G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 278 | 141 | $194 | |
J2250 |
Injection, midazolam hydrochloride, per 1 mg | 258 | 87 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 190 | 15 | $0 | |
G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 167 | 119 | $238 | |
J3010 |
Injection, fentanyl citrate, 0.1 mg | 164 | 87 | $1 | |
96127 |
Assessment of emotional or behavioral problems | 137 | 123 | $4 | |
Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 91 | 51 | $0 |
In context: peer comparison
Among 4 peers in Sugar Land Anesthesiology Physician, average services per provider: 79. This provider delivers 40× the peer median.Open Payments
Industry payments received
All-time total
$241
Transactions
4
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 2 | $201.25 | |
| Abbvie INC. | 2 | $40.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,553
Patients
1,007
Total drug cost
$69,247
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 1,418 | 419 | $46,380 |
| Gabapentin | Generic | 231 | 127 | $3,967 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 200 | 91 | $5,996 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 123 | 44 | $3,156 |
| Oxycodone Hcl | Generic | 112 | 59 | $1,794 |
| Tizanidine Hcl | Generic | 94 | 55 | $1,757 |
| Acetaminophen-Codeine (Acetaminophen With Codeine) | Brand | 73 | 47 | $997 |
| Pregabalin | Generic | 70 | 40 | $1,902 |
| Diclofenac Sodium | Generic | 47 | 36 | $747 |
| Topiramate | Generic | 43 | 0 | $649 |
Frequently asked questions
What is Dr. Asif Ali's medical specialty?
Dr. Asif Ali practices Anesthesiology Physician in Sugar Land, TX.
Where does Dr. Asif Ali practice?
Dr. Asif Ali practices at 12440 Emily CT Ste 701, Sugar Land, TX 774784543. Office phone: 4064768227.
What is Dr. Asif Ali's NPI?
Dr. Asif Ali's National Provider Identifier (NPI) is 1972941904, issued by NPPES.
Does Dr. Asif Ali accept Medicare assignment?
Yes. Dr. Asif Ali accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Asif Ali commonly perform?
Top Medicare-reported procedures in 2023: Testing for presence of drug, by chemistry analyzers (HCPCS 80307); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.